Back to top

Tale of the Tape

Zacks Equity Research

Calithera Biosciences (CALA) Jumps: Stock Rises 6.8%
October 04, 2016

TRLPF CALA

Trades from $3

Calithera Biosciences, Inc. (CALA - Free Report) was a big mover last session, as its shares rose almost 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $2.98 to $3.22 in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Calithera Biosciences currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked stock in the med-drugs space is Acerus Pharmaceuticals Corporation (TRLPF - Free Report) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>